NEW YORK, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of McKesson Corporation (“McKesson” or the “Company”) (: MCK). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/mck.
The investigation concerns whether McKesson and certain of its officers and/or directors have violated federal securities laws.
On January 25, 2017, McKesson announced its financial and operating results for the third quarter of fiscal year 2017. The Company reported an Adjusted Earnings per diluted share of $3.05, down 4% from the same period in the prior year, and further reported lower-than-expected Norther American Pharmaceutical Distribution and Services business unit revenue of $41.7 billion. McKesson informed investors that its disappointing financial results were “a result of the generic pricing actions [McKesson] began to implement late in our second quarter,” as McKesson’s “prices were ultimately set at a lower level than our initial expectations that were included in our previous guidance.” On this news, McKesson’s stock price fell $12.55 per share, or roughly 8.3%, to close at $138.55 per share on January 26, 2017.
If you are aware of any facts relating to this investigation, or purchased McKesson shares, you can assist this investigation by visiting the firm’s site: www.bgandg.com/mck. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
